Stocks and Investing Stocks and Investing
Tue, August 3, 2021

Joseph Pantginis Maintained (ATNM) at Strong Buy with Decreased Target to $45 on, Aug 3rd, 2021


Published on 2024-10-27 17:28:03 - WOPRAI, Joseph Pantginis
  Print publication without navigation


Joseph Pantginis of HC Wainwright & Co., Maintained "Actinium Pharmaceuticals, Inc." (ATNM) at Strong Buy with Decreased Target from $57 to $45 on, Aug 3rd, 2021.

Joseph, nor any peers, have made any analyst calls on ATNM in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources